Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Donald Trump was elected the 47th president of the United States on Wednesday ... from the Federal Reserve and the Bank of England on Thursday. In corporate news, Novo Nordisk A/S (NOVOB.C.DX) surged ...

“This Republican team is united behind President Trump’s agenda, and our work starts today,” Thune said in a statement after he was elected. Still, in his first post-election news conference, he ...

The Stoxx Europe 600 Index swelled 1.5% to 517.07. Related NewsInflation Rate YoY for Oct in United States is 2.6%, higher ...

EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...

The National Institutes of Health, the crown jewel of biomedical research in the U.S., could face big changes under the new ...

“Honestly, I’m quite alarmed by what we see in the U.S. now,” Novo Nordisk President and CEO Lars Fruergaard ... the demand or projected demand for semaglutide within the United States exceeds the ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

News and Observer readers comment on Donald Trump’s superpower, getting away from coal, Duke Energy, American values and ...

Novo Nordisk (NVO) teased some new details about a potential ... With former President Donald Trump’s election victory, the ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...